搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Metarhizium acridum Probable Xaa-Pro aminopeptidase MAC_04092 (MAC_04092), partial CSB-YP520699MRK
CSB-EP520699MRK
CSB-BP520699MRK
CSB-MP520699MRK
CSB-EP520699MRK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metarhizium robertsii Tethering factor for nuclear proteasome STS1 (STS1) CSB-YP520700MRM
CSB-EP520700MRM
CSB-BP520700MRM
CSB-MP520700MRM
CSB-EP520700MRM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Metarhizium robertsii Signal peptidase complex catalytic subunit SEC11 (SEC11), partial CSB-YP520701MRM1
CSB-EP520701MRM1
CSB-BP520701MRM1
CSB-MP520701MRM1
CSB-EP520701MRM1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Danio rerio Protein PET117 homolog, mitochondrial (pet117) CSB-YP520702DIL
CSB-EP520702DIL
CSB-BP520702DIL
CSB-MP520702DIL
CSB-EP520702DIL-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterococcus faecalis Cell division protein DivIB (divIB), partial CSB-YP520703ELU
CSB-EP520703ELU
CSB-BP520703ELU
CSB-MP520703ELU
CSB-EP520703ELU-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ajellomyces capsulata Signal peptidase complex catalytic subunit SEC11 (SEC11), partial CSB-YP520704AZB
CSB-EP520704AZB
CSB-BP520704AZB
CSB-MP520704AZB
CSB-EP520704AZB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine Protein-methionine sulfoxide oxidase MICAL2 (MICAL2), partial CSB-YP520705BO
CSB-EP520705BO
CSB-BP520705BO
CSB-MP520705BO
CSB-EP520705BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Chicken Ethylmalonyl-CoA decarboxylase (ECHDC1) CSB-YP520706CH
CSB-EP520706CH
CSB-BP520706CH
CSB-MP520706CH
CSB-EP520706CH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pig Multicilin (MCI) CSB-YP520707PI
CSB-EP520707PI
CSB-BP520707PI
CSB-MP520707PI
CSB-EP520707PI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pantoea ananatis Modulator protein MzrA (mzrA), partial CSB-YP520708ERB
CSB-EP520708ERB
CSB-BP520708ERB
CSB-MP520708ERB
CSB-EP520708ERB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Marinomonas mediterranea Lipid II flippase FtsW (ftsW), partial CSB-YP520709MQD
CSB-EP520709MQD
CSB-BP520709MQD
CSB-MP520709MQD
CSB-EP520709MQD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Enterococcus faecalis 3-dehydroquinate synthase (aroB) CSB-YP520710ELV
CSB-EP520710ELV
CSB-BP520710ELV
CSB-MP520710ELV
CSB-EP520710ELV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Boletus edulis Boletus edulis lectin CSB-YP520711BTP
CSB-EP520711BTP
CSB-BP520711BTP
CSB-MP520711BTP
CSB-EP520711BTP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus buchneri NAD (P)H-hydrate epimerase CSB-YP520712LMG
CSB-EP520712LMG
CSB-BP520712LMG
CSB-MP520712LMG
CSB-EP520712LMG-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Putative UDP-glucuronate:xylan alpha-glucuronosyltransferase 5 (GUX5), partial CSB-YP520713DOA1
CSB-EP520713DOA1
CSB-BP520713DOA1
CSB-MP520713DOA1
CSB-EP520713DOA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Ferric reduction oxidase 3, mitochondrial (FRO3), partial CSB-YP520714DOA
CSB-EP520714DOA
CSB-BP520714DOA
CSB-MP520714DOA
CSB-EP520714DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana ATPase family AAA domain-containing protein At1g05910 (At1g05910), partial CSB-YP520715DOA
CSB-EP520715DOA
CSB-BP520715DOA
CSB-MP520715DOA
CSB-EP520715DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Preprotein translocase subunit SCY2, chloroplastic (SCY2), partial CSB-YP520716DOA
CSB-EP520716DOA
CSB-BP520716DOA
CSB-MP520716DOA
CSB-EP520716DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana WEB family protein At4g27595, chloroplastic (At4g27595), partial CSB-YP520717DOA
CSB-EP520717DOA
CSB-BP520717DOA
CSB-MP520717DOA
CSB-EP520717DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Protein BASIC PENTACYSTEINE5 (BPC5) CSB-YP520718DOA
CSB-EP520718DOA
CSB-BP520718DOA
CSB-MP520718DOA
CSB-EP520718DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>